MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
| hmdb:HMDB0056555 XHDPRPBHXDDINI-FSTLVUEISA-N | CL(16:0/16:1(9Z)/18:1(11Z)/16:0) (2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(hexadecanoyloxy)propoxy((2R)-3-{[(2R)-2-(hexadecanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy)phosphinic acid 1'-[1-Hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho],3'-[1,2-di(11Z-octadecenoyl)-rac-glycero-3-phospho]-glycerol 1'-[1-Palmitoyl-2-palmitoleoyl-sn-glycero-3-phospho],3'-[1,2-divaccenoyl-rac-glycero-3-phospho]-glycerol CL(1'-[16:0/16:1(9Z)],3'-[18:1(11Z)/18:1(11Z)]) CL(16:0/16:1/18:1/18:1) CL(68:3) Cardiolipin(16:0/16:1/18:1/18:1) Cardiolipin(68:3) [(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(hexadecanoyloxy)propoxy][(2R)-3-({[(2R)-2-(hexadecanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphinic acid |
SLM:000511044 slm:000511044 XHDPRPBHXDDINI-RWDBNWLLSA-L | Cardiolipin (16:0/16:1(9Z)/18:1(11Z)/16:0) 1'-[1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho],3'-[1-(11Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho]-glycerol CL (16:0/16:1(9Z)/18:1(11Z)/16:0) |
hmdb:HMDB56555 | secondary/obsolete/fantasy identifier |